TALK
Talkspace, Inc.NASDAQHealthcare$5.18+0.39%ClosedMarket Cap: $865.5M
As of 2026-04-06
Valuation
P/E (TTM)
111.06
PEG
0.26
P/B
7.48
P/S
3.80
EV/EBITDA
69.92
DCF Value
$-9.64
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
43.0%
Operating Margin
1.4%
Net Margin
3.4%
ROE
6.9%
ROA
5.8%
ROIC
2.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $63.0M | 42.7% | $3.8M | $4.8M | $0.03 | — |
| FY 2025 | $228.9M | 43.0% | $3.2M | $7.8M | $0.04 | — |
| Q3 2025 | $59.4M | 41.7% | $2.2M | $3.3M | $0.02 | — |
| Q2 2025 | $54.3M | 43.1% | $-1.8M | $-541.0K | $-0.00 | — |
| Q1 2025 | $52.2M | 44.6% | $-1.1M | $318.0K | $0.00 | — |
| Q4 2024 | $48.7M | 44.2% | $569.0K | $1.2M | $0.01 | — |
| FY 2024 | $187.6M | 45.8% | $-4.5M | $1.1M | $0.01 | — |
| Q3 2024 | $47.4M | 45.6% | $99.0K | $-1.7M | $0.01 | — |
| Q2 2024 | $46.1M | 45.7% | $-3.5M | $-474.0K | $-0.00 | — |
| Q1 2024 | $45.4M | 47.8% | $-1.7M | $-1.5M | $-0.01 | — |
| Q4 2023 | $42.4M | 49.4% | $-2.6M | $-1.3M | $-0.01 | — |
| FY 2023 | $150.0M | 49.6% | $-23.2M | $-19.2M | $-0.12 | — |